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SHORTCOMMUNICATION
Acute Phase Response in Patients with
Uncomplicatedand ComplicatedEndoscopic
RetrogradicCholangiopancreaticography
HEIKKI KIVINIEMI, TATU JUVONEN and JYRKI MKEL
Department ofSurgery, Oulu University Hospital, FIN-90220 Oulu, Finland
Acutephase response afterendoscopic retrogradiccholangiopancreatcography(ERCP)was studied
in 42 patients with suspected pancreatic or biliary diseases. In uncomplicated cases acute phase
response determined by serum C-reactive protein levels was rare and did not parallel the serum
amylase or lipase levels. In three ofthe these42 patients, post-ERCP pancreatitisdevelopedandCRP
levels elevated sharply and paralleled the degree ofpancreatitis. Six additional patients outside ofthis
prospective studywithpost-ERCP-pancreatitisand dailyCRP determinationswereused to determine
the CRP-response curve inpost-ERCP pancreatitis.
INTRODUCTION
The clinical symptoms after endoscopic retrogradic
cholangiopancreaticography (ERCP) are usually mode-
rate, but acute pancreatitis has been described in 1-7% 1-3.
Hyperamylasemia followingERCP, as a sign ofpancreatic
injury, occurs in up to 70% 4, after endoscopic pancre-
aticography (ERP). Lipase has been suggested to be an
even more sensitive indicator of pancreatic injury than
amylase 6. According to recent reportsC -reactive protein
(CRP), an acute phase protein secreted by hepatocytes--is
valuable in estimation of tissue injury and infectious
complications 8. Our purpose was to studyCRP response
in uncomplicated and complicated ERCP.
MATER]AtANDMETHODS
ERCP was performed in 42 consecutive patients with
suspected pancreatic or biliary diseases, in a prospective
manner. Before the examination the patients received
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sedation and anticholinergic agent(BuscopanR) to reduce
gut mobility during the study. The blood samples were
drawn for estimation ofamylase, lipase andCRP values
before cannulation of the papilla of Vater (n 42), six
hours after (n 42), twenty-four hours after (n = 42)
cannulation.
The serum amylase and lipase values were determined
automatically. CRP was measured using an immuno-
turbidicmethod (9), with reference < 12mg per liter.
The patients were discharged from the hospital 24
hours afterERCP ifno complications occurred. In cases
ofsuspected acute pancreatitis amylase, lipase andCRP
values were determined daily. Six additional patients with
post-ERCP pancreatitis with dailyCRP determinations
were included in the study in order to formulate CRP
response curve in post-ERCP pancreatitis. These
patients did not belong to the prospective series of
42 patients, being treated befo’e the beginning of this
prospective series.
RESULTS
Visualization of the pancreatic duct only (ERP) was
successful in 22 cases, both the pancreatic duct and bile
duct(ERCP) in 16 cases and the bile duct only in 4 cases.130 HEIKKI KIVINIEMI et al.
Table I SerumC-reactiveprotein(CRP), lipaseandamylase levels
after ERCP in 42 patients
C-reactiveprotein (rag 6hours 24hours
<13 39 39
13-20 3" 2"
> 20 0 1"
Lipase (U/I)
< 160 16 21
160-300 9 8
> 300 17" 13"
Amylase(U/I)
< 300 20 25
3(X)-(O) 13 6
> 600 9" 11"
* Three patients with post ERCP pancreatitis are included in the
group.
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Figure2 C-reactive protein response in a patient withpost-ERCP
pancreatitis(A)andacutehaemorl’hagicpancreatitis (B). Thearrow
indicates the time of surgical intervention.
The behaviour ofCRP, amylase and lipase did not differ
between the groups and are presented in Table I. In
uncomplicated cases lipase ismost sensitive, whereasCRP
elevation above the reference rangewas rare. In 5 patients
with uncomplicatedERCPCRP values stayed normal for
up to forty-eight hours ofthe study (data not shown). In 3
of the 42 prospective patients acute pancreatitis (AP)
developed, lipase and amylase was raised markedly in
these patients, a strongCRP responsewas also seen on the
second day after the cannulation ofthe papilla ofVater.
In addition to these 3 patients with AP, 6 additional
patients with post-ERCP pancreatitis with daily CRP
determinations were studied retrospectively. The CRP
response in these 9 patients withpost-ERCP pancreatitis
is seen in Figure 1. Two ofthese patients had a fulminant
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Figure I C-reactiveprotein response in9 patientswithpost-ERCP
pancreatitis.
form of acute pancreatitis and were operated on.
Debridementwas performed in these patients. There was
no mortality. A typical CRP-response curve in nonhae-
morrhagic and fulminant case, respectively, is presented
in Figure 2.
DISCUSSION
The development ofpost-ERCP pancreatitis is a serious
complication associated with fulminant forms of the
diseasel and also with mortality. CRP is helpful in
monitoring and assessing the severity of acute
pancreatitis12. When the patients are admitted to hospital
with acute pancreatitis, they have variable symptoms.
Often the time ofonset ofnon-ERCP-pancreatitis cannot
be estimated exactly andCRP response is variable (13). In
post-ERCP pancreatitis the time of cannulation and
injection ofcontrastmedium isknown andCRP response
curve can be estimated accurately. In all our patients, the
initialCRP valueswere normal.
In accordance with other studies (6) serum lipase and
amylase were elevated very early in over 50% ofuncom-
plicated ERCP cases, whereas CRP reponse could be
seen very rarely. So, CRP seems not to be a sensitive
indicator ofenzyme release.
In cases ofpost-ERCP pancreatitisCRP the response
was substantial, showing highly elevated values at48 hours
after ERCP (mostly over 100 mg/1). The delay in this
response depends on mediators, such as interleukin-1,
14 which are essential to the acute phase response Many
patients with post-ERCP pancreatitis get necrosis5
and pain is a most important sign of this developing
complication. Two of our nine post-ERCP pancreatitisSHORTCOMMUNICATION 131
patients were severe (22 %). According to recent literature
severe pancreatitis afterERCP develops in 16% ofcases15.
The determination ofCRP response in suspected post-
ERCP pancreatitis is obviously useful, because it reflects-
in contrast to amylase and lipasethe degree of pan-
creatic injury and the course ofthe disease episode.
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